In a filing, Palisade Bio Inc revealed its Director Williams Donald Allen acquired Company’s shares for reported $4863.0 on May 28 ’24. In the deal valued at $4.86 per share,1,000 shares were bought. As a result of this transaction, Williams Donald Allen now holds 1,000 shares worth roughly $830.0.
Then, Finley John David bought 1,000 shares, generating $4,810 in total proceeds. Upon buying the shares at $4.81, the CEO, CFO, Director now owns 8,437 shares.
Price Performance Review of PALI
On Tuesday, Palisade Bio Inc [NASDAQ:PALI] saw its stock jump 6.07% to $0.83. Over the last five days, the stock has gained 10.48%. Palisade Bio Inc shares have fallen nearly -49.41% since the year began. Nevertheless, the stocks have fallen -88.55% over the past one year. While a 52-week high of $8.57 was reached on 01/07/25, a 52-week low of $0.60 was recorded on 04/04/25. SMA at 50 days reached $0.7689, while 200 days put it at $2.2319.
Levels Of Support And Resistance For PALI Stock
The 24-hour chart illustrates a support level at 0.7163, which if violated will result in even more drops to 0.5977. On the upside, there is a resistance level at 0.8941. A further resistance level may holdings at 0.9533. The Relative Strength Index (RSI) on the 14-day chart is 61.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0559, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 0.00%. Stochastics %K at 83.15% indicates the stock is a selling.
